NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0484944/Epidemiology-Schizophrenia.html
In this analysis, Datamonitor highlights that schizophrenia is and will remain an important health burden in the seven major healthcare markets. However, the number of schizophrenia patients will remain fairly constant over the next 10 years. The highest increase in the number of cases will be in the US, with the majority of the seven major markets posting minor increases. Gain insight to market potential, including a robust 10 year epidemiology forecast of schizophrenia prevalent cases Understand the key epidemiologic risk factors associated with schizophrenia In 2009, in the seven major healthcare markets, there were about four and half million men and women with schizophrenia—almost half of these were in the US. Between 2009 and 2019, the number of schizophrenia prevalent cases will increase marginally in these markets. Since the 1950s, when robust epidemiologic studies coupled with improved disease classification and diagnosis criteria, the incidence and prevalence of schizophrenia seem to have remained constant over time even though with small variations due to these diagnostic criteria. What are the most robust sources for schizophrenia prevalence data? How will the patient population change over the next decade in the US, Japan and the five major EU markets (France, Germany, Italy, Spain and the UK)?How do changes in population structure and risk factors affect the trend in prevalent schizophrenia cases?
Executive Summary
Prevalence and trends
Disease etiology
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Module scope
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Disease diagnosis criteria
GLOBAL VARIATION AND HISTORICAL TRENDS
Similar rates across countries
Contemporary trends
RISK FACTORS
Genetics
Season of birth
Infections and the immune system
Ethnicity and migration
EPIDEMIOLOGIC FORECASTING OF SCHIZOPHRENIA
Sources of epidemiologic data
UK
US
Italy
France
Spain
Germany
Japan
Population denominators
Categorization and stratification
Description of methods
EPIDEMIOLOGIC RESULTS
Current prevalent cases and future trends of schizophrenia
DISCUSSION
Strengths of our epidemiologic projections
Bibliography
APPENDIX
Module methodology
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article